{"entity":{"type":"insider","cik":"0001816210","url":"/insider/0001816210","json_url":"/insider/0001816210.json","name":"Patel Sanjiv","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":17,"first":"2020-07-21","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Patel Sanjiv","source":"filing","n_filings":17,"first_seen":"2020-07-21","last_seen":"2026-08-18"}],"transactions":[{"id":9255866,"accession":"0001193125-26-355502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-355502","line_url":"/filing/0001193125-26-355502#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48199.0,"shares_display":"48,199","price_per_share":20.33,"price_display":"20.33","price_state":"stated","total_value":979885.67,"total_display":"979,885.67","total_whole":"979,886","shares_owned_after":567699.0,"shares_owned_after_display":"567,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":5908167,"accession":"0001193125-26-298681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-298681","line_url":"/filing/0001193125-26-298681#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48199.0,"shares_display":"48,199","price_per_share":19.58,"price_display":"19.58","price_state":"stated","total_value":943736.42,"total_display":"943,736.42","total_whole":"943,736","shares_owned_after":615898.0,"shares_owned_after_display":"615,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-08","scope":"insider"},{"id":6000703,"accession":"0001193125-26-006328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-006328","line_url":"/filing/0001193125-26-006328#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43168.0,"shares_display":"43,168","price_per_share":7.82,"price_display":"7.82","price_state":"stated","total_value":337573.76,"total_display":"337,573.76","total_whole":"337,574","shares_owned_after":661041.0,"shares_owned_after_display":"661,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-07","scope":"insider"},{"id":4298326,"accession":"0001193125-25-264700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-264700","line_url":"/filing/0001193125-25-264700#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62073.0,"shares_display":"62,073","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":434511.0,"total_display":"434,511.00","total_whole":"434,511","shares_owned_after":703215.0,"shares_owned_after_display":"703,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-04","scope":"insider"},{"id":4497056,"accession":"0000950170-25-095093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-095093","line_url":"/filing/0000950170-25-095093","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61379.0,"shares_display":"61,379","price_per_share":3.57,"price_display":"3.57","price_state":"stated","total_value":219123.03,"total_display":"219,123.03","total_whole":"219,123","shares_owned_after":783927.0,"shares_owned_after_display":"783,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-10","scope":"insider","n_lines":2},{"id":4059752,"accession":"0000950170-25-057996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-057996","line_url":"/filing/0000950170-25-057996","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61422.0,"shares_display":"61,422","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":182423.34,"total_display":"182,423.34","total_whole":"182,423","shares_owned_after":840320.0,"shares_owned_after_display":"840,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-23","filed_date":"2025-04-24","scope":"insider","n_lines":2},{"id":4375990,"accession":"0000950170-25-020272","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-020272","line_url":"/filing/0000950170-25-020272#line-3","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75324.0,"shares_display":"75,324","price_per_share":3.7,"price_display":"3.70","price_state":"stated","total_value":278698.8,"total_display":"278,698.80","total_whole":"278,699","shares_owned_after":883089.0,"shares_owned_after_display":"883,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-13","scope":"insider"},{"id":4375986,"accession":"0000950170-25-020272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-020272","line_url":"/filing/0000950170-25-020272#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140182.0,"shares_display":"140,182","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":539700.7,"total_display":"539,700.70","total_whole":"539,701","shares_owned_after":625948.0,"shares_owned_after_display":"625,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-13","scope":"insider"},{"id":4339854,"accession":"0000950170-25-008451","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-008451","line_url":"/filing/0000950170-25-008451#line-3","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":597500.0,"total_display":"597,500.00","total_whole":"597,500","shares_owned_after":199548.0,"shares_owned_after_display":"199,548","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-23","filed_date":"2025-01-23","scope":"insider"},{"id":4339851,"accession":"0000950170-25-008451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-008451","line_url":"/filing/0000950170-25-008451#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":600000.0,"total_display":"600,000.00","total_whole":"600,000","shares_owned_after":324548.0,"shares_owned_after_display":"324,548","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4339847,"accession":"0000950170-25-008451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-008451","line_url":"/filing/0000950170-25-008451#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":565000.0,"total_display":"565,000.00","total_whole":"565,000","shares_owned_after":449548.0,"shares_owned_after_display":"449,548","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":2394956,"accession":"0000950170-24-137960","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-137960","line_url":"/filing/0000950170-24-137960#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":574548.0,"shares_owned_after_display":"574,548","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":3152715,"accession":"0000950170-24-087435","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-087435","line_url":"/filing/0000950170-24-087435#line-4","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36706.0,"shares_display":"36,706","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":332923.42,"total_display":"332,923.42","total_whole":"332,923","shares_owned_after":766130.0,"shares_owned_after_display":"766,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-26","filed_date":"2024-07-29","scope":"insider"},{"id":3152713,"accession":"0000950170-24-087435","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-087435","line_url":"/filing/0000950170-24-087435#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":9.16,"price_display":"9.16","price_state":"stated","total_value":458000.0,"total_display":"458,000.00","total_whole":"458,000","shares_owned_after":766130.0,"shares_owned_after_display":"766,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-29","scope":"insider"},{"id":8436007,"accession":"0001209191-23-008072","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-008072","line_url":"/filing/0001209191-23-008072#line-6","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":20.55,"price_display":"20.55","price_state":"stated","total_value":287700.0,"total_display":"287,700.00","total_whole":"287,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-09","scope":"insider"},{"id":8435998,"accession":"0001209191-23-008072","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-008072","line_url":"/filing/0001209191-23-008072#line-4","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":20.98,"price_display":"20.98","price_state":"stated","total_value":293720.0,"total_display":"293,720.00","total_whole":"293,720","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-09","scope":"insider"},{"id":8435986,"accession":"0001209191-23-008072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-008072","line_url":"/filing/0001209191-23-008072#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":21.45,"price_display":"21.45","price_state":"stated","total_value":300300.0,"total_display":"300,300.00","total_whole":"300,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-09","scope":"insider"},{"id":8362772,"accession":"0001209191-23-004127","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-004127","line_url":"/filing/0001209191-23-004127#line-6","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":20.02,"price_display":"20.02","price_state":"stated","total_value":560560.0,"total_display":"560,560.00","total_whole":"560,560","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-19","scope":"insider"},{"id":8362768,"accession":"0001209191-23-004127","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-004127","line_url":"/filing/0001209191-23-004127#line-4","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":20.87,"price_display":"20.87","price_state":"stated","total_value":584360.0,"total_display":"584,360.00","total_whole":"584,360","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":8362760,"accession":"0001209191-23-004127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-004127","line_url":"/filing/0001209191-23-004127#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":20.23,"price_display":"20.23","price_state":"stated","total_value":566440.0,"total_display":"566,440.00","total_whole":"566,440","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6673623,"accession":"0001209191-22-056427","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-056427","line_url":"/filing/0001209191-22-056427","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":560000.0,"total_display":"560,000.00","total_whole":"560,000","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-10","scope":"insider","n_lines":2},{"id":6673603,"accession":"0001209191-22-056427","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-056427","line_url":"/filing/0001209191-22-056427#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":20.18,"price_display":"20.18","price_state":"stated","total_value":282520.0,"total_display":"282,520.00","total_whole":"282,520","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-10","scope":"insider"},{"id":6957230,"accession":"0001209191-22-053597","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-053597","line_url":"/filing/0001209191-22-053597#line-6","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":20.58,"price_display":"20.58","price_state":"stated","total_value":288120.0,"total_display":"288,120.00","total_whole":"288,120","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-13","scope":"insider"},{"id":6957224,"accession":"0001209191-22-053597","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-053597","line_url":"/filing/0001209191-22-053597#line-4","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":21.18,"price_display":"21.18","price_state":"stated","total_value":296520.0,"total_display":"296,520.00","total_whole":"296,520","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-12","filed_date":"2022-10-13","scope":"insider"},{"id":6957218,"accession":"0001209191-22-053597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053597","line_url":"/filing/0001209191-22-053597#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":21.36,"price_display":"21.36","price_state":"stated","total_value":299040.0,"total_display":"299,040.00","total_whole":"299,040","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-13","scope":"insider"},{"id":6330812,"accession":"0001209191-22-050182","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-050182","line_url":"/filing/0001209191-22-050182#line-6","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":23.8,"price_display":"23.80","price_state":"stated","total_value":333200.0,"total_display":"333,200.00","total_whole":"333,200","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-15","scope":"insider"},{"id":6330804,"accession":"0001209191-22-050182","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-050182","line_url":"/filing/0001209191-22-050182#line-4","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":23.47,"price_display":"23.47","price_state":"stated","total_value":328580.0,"total_display":"328,580.00","total_whole":"328,580","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-15","scope":"insider"},{"id":6330797,"accession":"0001209191-22-050182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-050182","line_url":"/filing/0001209191-22-050182#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":25.45,"price_display":"25.45","price_state":"stated","total_value":356300.0,"total_display":"356,300.00","total_whole":"356,300","shares_owned_after":254554.0,"shares_owned_after_display":"254,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-15","scope":"insider"},{"id":6543323,"accession":"0001209191-22-024487","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-22-024487","line_url":"/filing/0001209191-22-024487","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":30.51,"price_display":"30.51","price_state":"stated","total_value":854280.0,"total_display":"854,280.00","total_whole":"854,280","shares_owned_after":253740.0,"shares_owned_after_display":"253,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-14","filed_date":"2022-04-14","scope":"insider","n_lines":2},{"id":6543309,"accession":"0001209191-22-024487","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-024487","line_url":"/filing/0001209191-22-024487","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":31.95,"price_display":"31.95","price_state":"stated","total_value":894600.0,"total_display":"894,600.00","total_whole":"894,600","shares_owned_after":253740.0,"shares_owned_after_display":"253,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-13","filed_date":"2022-04-14","scope":"insider","n_lines":2},{"id":6543298,"accession":"0001209191-22-024487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-024487","line_url":"/filing/0001209191-22-024487#line-2","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28000.0,"shares_display":"28,000","price_per_share":31.8,"price_display":"31.80","price_state":"stated","total_value":890400.0,"total_display":"890,400.00","total_whole":"890,400","shares_owned_after":253740.0,"shares_owned_after_display":"253,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider"},{"id":3161837,"accession":"0000899243-20-019847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-019847","line_url":"/filing/0000899243-20-019847#line-1","is_derivative":false,"issuer_cik":"0001812364","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001812364","owner_cik":"0001816210","owner_name":"Patel Sanjiv","owner_display_name":"Patel Sanjiv","owner_url":"/insider/0001816210","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":403082.0,"shares_owned_after_display":"403,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001812364","name":"Relay Therapeutics, Inc.","url":"/issuer/0001812364","role":"Director, Officer (President and CEO)","n_filings":17,"first_seen":"2020-07-21","last_seen":"2026-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001816210","retrieved_at":"2026-08-24T08:47:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}